Surrozen Statistics
NASDAQ: SRZNHealthcareBiotechnologyUSD
25.15-1.23 (-4.65%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
Surrozen by the numbers
Surrozen has a market capitalization of $295.5 million based on 11.75M shares outstanding. With trailing EPS of $-37.27, Surrozen is unprofitable on a 12-month basis, so earnings-based valuation ratios do not apply. The stock trades 9.1% above its 50-day average and 2.2% above its 200-day average.
Average daily trading volume is 471.01K shares, or about $11.8 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
SRZN valuation vs. peer median
| Metric | SRZN | Peer median | Difference |
|---|---|---|---|
| Market cap | $295.54M | $288.09M | +3% |
| Avg. volume | 471.01K | 1.08M | -57% |
Peer median across 8 companies: CUVL, ABEO, INDP, LRMR, PRLD, FULC, XFOR, EYPT.
Valuation
- Market cap
- $295.54M
- EPS (TTM)
- $-37.27
- Shares outstanding
- 11.75M
Price and trading
- Previous close
- 26.37
- Open
- 25.81
- Day range
- 25.08 – 26.18
- 52-week range
- 11.39 – 37.83
- 52-week change
- +82.87%
- Beta
- —
- Volume
- 374.21K
- Average volume
- 471.01K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 6, 2026
Additional statistics
- Market Cap
- 295.54M
- Forward Pe
- -6.01
- Eps
- -37.27
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 37.83
- Week52 Low
- 11.39
- Avg Volume
- 471.01K
- Shares Outstanding
- 11.75M
- Ma50
- 23.06
- Ma200
- 24.61
- Earnings Date
- Nov 6, 2026
- Pct From52w High
- -33.53%
- Pct From52w Low
- 120.76%